A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic, or Open Liver Resection for Patients With BCLC Stage 0-A Hepatocellular Carcinoma
- PMID: 35081573
- DOI: 10.1097/SLA.0000000000005380
A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic, or Open Liver Resection for Patients With BCLC Stage 0-A Hepatocellular Carcinoma
Abstract
Objective: To compare the short- and long-term outcomes of robot-assisted (RALR), laparoscopic (LLR), or open liver resection (OLR) in the treatment of Barcelona Clinic Liver Cancer (BCLC) stage 0-A hepatocellular carcinoma (HCC).
Summary background data: Following the Balliol IDEAL classification, long-term oncological outcomes can be used to evaluate the value of minimally invasive techniques in the treatment of HCC, and to assess whether they should become a standard practice.
Methods: Data from prospective cohorts of patients with BCLC stage 0-A HCC who underwent curative liver resection using OLR, LLR, or RALR at Tongji Hospital were reviewed. The short-term and long-term oncological outcomes of these 3 different surgical approaches after adequate follow-up were compared using propensity score matching to reduce selection bias.
Results: Of 369 patients included in this study (71, RALR; 141, LLR; and 157, OLR), 56 patients in each of the 3 groups were chosen for further comparison, after propensity score matching. In the minimally invasive group (RALR+LLR), both the operative time and duration of Pringle's maneuver were significantly longer than those in the OLR group; however, the length of hospital stay was significantly shorter. There were no significant differences in the other intraoperative parameters and the incidence of postoperative complications among the 3 groups. HCC recurrence in the minimally invasive group when compared with the OLR group was characterized by a significantly higher proportion of single lesion or early-stage HCC. However, there were no significant differences in the 5-year disease-free survival (63.8%, 54.4%, and 50.6%) or overall survival rates (80.8%, 78.6%, and 75.7%, respectively) among the 3 groups. Clinically significant portal hypertension was the only risk factor that negatively affected the 5-year disease-free survival rate. Multivariate Cox regression analysis showed that clinically significant portal hypertension, serum alpha-fetoprotein level (≥400 ng/mL), and Edmondson-Steiner grading (III+IV) were independent risk factors for poor long-term survival.
Conclusion: Both robotic and laparoscopic hepatectomies were safe and effective for patients with BCLC stage 0-A HCC when compared with open hepatectomy.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors report no conflicts of interest.
Comment in
-
Minimally invasive hepatectomy is here to stay, but more evidence is needed.Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):619-621. doi: 10.21037/hbsn-23-309. Epub 2023 Jul 4. Hepatobiliary Surg Nutr. 2023. PMID: 37600979 Free PMC article. No abstract available.
-
The future of minimally invasive liver resection for hepatocellular carcinoma BCLC stage 0-A.Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):601-603. doi: 10.21037/hbsn-23-295. Epub 2023 Jul 4. Hepatobiliary Surg Nutr. 2023. PMID: 37600996 Free PMC article. No abstract available.
-
Modern surgical approach to hepatocellular carcinoma.Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):953-955. doi: 10.21037/hbsn-23-535. Epub 2023 Nov 15. Hepatobiliary Surg Nutr. 2023. PMID: 38115938 Free PMC article. No abstract available.
References
-
- Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBO- CAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–249.
-
- Zhang S, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2015. J Natl Cancer Center. 2021;1:2–11.
-
- Vogel A, Cervantes A, Chau I, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30:871–873.
-
- Coelho FF, Kruger JA, Fonseca GM, et al. Laparoscopic liver resection: experience based guidelines. World J Gastrointest Surg. 2016;8:5–26.
-
- Han HS, Shehta A, Ahn S, et al. Laparoscopic versus open liver resection for hepatocellular carcinoma: case-matched study with propensity score matching. J Hepatol. 2015;63:643–650.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
